Differences

This shows you the differences between two versions of the page.

Link to this comparison view

meds:agitation [on May 16, 2019]
 meds:agitation [on September 14, 2020]
Line 1: Line 1:
-{{tag>​rx}} 
 ====== Pharmacological Management of Acute Agitation ====== ====== Pharmacological Management of Acute Agitation ======
 {{INLINETOC}} {{INLINETOC}}
Line 19: Line 18:
  
 <panel type="​info"​ title="​Haloperidol versus Loxapine"​ subtitle="​Adapted from Procyshyn, Ric M., Kalyna Z. Bezchlibnyk-Butler,​ and J. Joel Jeffries. Clinical Handbook of Psychotropic Drugs. Hogrefe, 2017." no-body="​true">​ <panel type="​info"​ title="​Haloperidol versus Loxapine"​ subtitle="​Adapted from Procyshyn, Ric M., Kalyna Z. Bezchlibnyk-Butler,​ and J. Joel Jeffries. Clinical Handbook of Psychotropic Drugs. Hogrefe, 2017." no-body="​true">​
-!^!                  ^ Description ​                                           ^ Haloperidol ​ ^ Loxapine ​     ^+<​mobiletable 1> 
 +^                  ^ Description ​                                           ^ Haloperidol ​ ^ Loxapine ​     ^
 ^ Potency ​           | The amount of medication that needs to be given        | High         | Intermediate ​ | ^ Potency ​           | The amount of medication that needs to be given        | High         | Intermediate ​ |
 ^ D2 Antagonism ​     | Amount of antipsychotic effect, and EPS risk           | +++++        | ++++          | ^ D2 Antagonism ​     | Amount of antipsychotic effect, and EPS risk           | +++++        | ++++          |
Line 25: Line 25:
 ^ 5-HT2 Antagonism ​  | Amount of anxiolytic effect/​sedation ​                  | +/+++        | +++/​++++ ​     | ^ 5-HT2 Antagonism ​  | Amount of anxiolytic effect/​sedation ​                  | +/+++        | +++/​++++ ​     |
 ^ ACh M1 Antagonism ​ | Mitigation of EPS, sedation ​                           | +            | ++            | ^ ACh M1 Antagonism ​ | Mitigation of EPS, sedation ​                           | +            | ++            |
 +</​mobiletable>​
 </​panel>​ </​panel>​
  
Line 85: Line 86:
 == For Providers == == For Providers ==
   * [[http://​escholarship.org/​uc/​item/​5fz8c8gs|Wilson,​ Michael P.; Pepper, David; Currier, Glenn W.; Holloman, Garland H.; & Feifel, David. (2012). The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. Western Journal of Emergency Medicine, 13(1).]]   * [[http://​escholarship.org/​uc/​item/​5fz8c8gs|Wilson,​ Michael P.; Pepper, David; Currier, Glenn W.; Holloman, Garland H.; & Feifel, David. (2012). The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. Western Journal of Emergency Medicine, 13(1).]]
 +  * [[https://​www.psychiatryadvisor.com/​home/​opinion/​haloperidol-in-the-emergency-department-setting/​|PsychiatryAdvisor:​ Haloperidol in the Emergency Department Setting]]
  
 +{{tag>​rx}}